A researcher at Northeastern University has found a groundbreaking new way to diagnose people with sleep apnea that could ...

Citing topline data, the Indiana-based pharma giant said tirzepatide, marketed as Zepbound and Wegovy, significantly reduced the apnea-hypopnea index (AHI), trials' primary endpoints, compared to ...